These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6049100)
1. Identity of a urinary "pink spot" in schizophrenia and Parkinson's disease. Boulton AA; Pollitt RJ; Majer JR Nature; 1967 Jul; 215(5097):132-4. PubMed ID: 6049100 [No Abstract] [Full Text] [Related]
2. The identity of the so-called pink spot in schizophrenia and Parkinson's disease. Heslinga FJ; van Tilburg W; Stam FC Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324 [No Abstract] [Full Text] [Related]
3. Some observations concerning the "pink spot" reacting substances in urine. Watt JA; Ashcroft GW; Daly RJ; Smythies JR Acta Psychiatr Scand; 1970; 46(4):374-90. PubMed ID: 5502783 [No Abstract] [Full Text] [Related]
5. A pink spot in thyrotoxicosis. Widelitz M; Feldman W Biol Psychiatry; 1971; 3(2):181-4. PubMed ID: 5089913 [No Abstract] [Full Text] [Related]
6. Schizophrenia and pink spot. Stam FC; Heslinga FJ; van Tilburg W Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242 [No Abstract] [Full Text] [Related]
7. Pink spot, p-tyramine and schizophrenia. Vogel WH; Ahlberg CD; Di Carlo V; Horwitt MK Nature; 1967 Dec; 216(5119):1038-9. PubMed ID: 6066560 [No Abstract] [Full Text] [Related]
8. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia. Barbeau A Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100 [No Abstract] [Full Text] [Related]
9. Urinary amines in chronic schizophrenia. Perry TL; Hansen S; MacDougall L Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580 [No Abstract] [Full Text] [Related]
11. Urinary excretion of 3,4-dimethoxyphenylethylamine in Parkinson's disease. Rinne UK; Sonninen V Nature; 1967 Nov; 216(5114):489. PubMed ID: 6057254 [No Abstract] [Full Text] [Related]
12. Is brain damage the cause of "pink spot"? Nunn RF; Wheeler RH Nature; 1966 Nov; 212(5065):939. PubMed ID: 6004582 [No Abstract] [Full Text] [Related]
13. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)]. Stanciu E; Csiky K; Rácz E Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389 [No Abstract] [Full Text] [Related]
14. Identity of the "pink spot". Bell CE; Somerville AR Nature; 1966 Sep; 211(5056):1405-6. PubMed ID: 5969836 [No Abstract] [Full Text] [Related]
15. The "pink spot," 3,4-dimethoxyphenylethylamine, common tea, and schizophrenia. Stabenau JR; Creveling CR; Daly J Am J Psychiatry; 1970 Nov; 127(5):611-6. PubMed ID: 5491537 [No Abstract] [Full Text] [Related]
16. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"]. Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A Encephale; 1969; 58(4):360-76. PubMed ID: 5378191 [No Abstract] [Full Text] [Related]
17. The "pink spot" in schizophrenics and its absence in homocystinurics. Welch JP; Clower CG; Schimke RN Br J Psychiatry; 1969 Feb; 115(519):163-7. PubMed ID: 5778193 [No Abstract] [Full Text] [Related]
18. The "pink spot" and schizophrenia. Boulton AA; Felton CA Nature; 1966 Sep; 211(5056):1404-5. PubMed ID: 5969835 [No Abstract] [Full Text] [Related]
19. Effect of L-dopa therapy on urinary p-tyramine excretion and EEG changes in Parkinson's disease. Boulton AA; Marjerrison GL Nature; 1972 Mar; 236(5341):76-8. PubMed ID: 4553458 [No Abstract] [Full Text] [Related]
20. Investigations on urinary excretion of 3,4 dimethoxyphenylethylamine (the pink spot), the Mauve factor and aromatic compounds in patients with schizophrenia. Rao BS; Narayanan HS; Reddy GN Indian J Med Res; 1971 Mar; 59(3):455-60. PubMed ID: 5090025 [No Abstract] [Full Text] [Related] [Next] [New Search]